Drinking Intensity at Age 29/30 as a Predictor of Alcohol Use Disorder Symptoms at Age 35 in a National Sample.


Journal

Journal of studies on alcohol and drugs
ISSN: 1938-4114
Titre abrégé: J Stud Alcohol Drugs
Pays: United States
ID NLM: 101295847

Informations de publication

Date de publication:
05 2021
Historique:
entrez: 8 6 2021
pubmed: 9 6 2021
medline: 26 11 2021
Statut: ppublish

Résumé

The purpose of this longitudinal study was to identify associations of drinking intensity at age 29/30 with symptoms of alcohol use disorder (AUD) at age 35. Analyses used national longitudinal data from 1,253 individuals (53.5% female) participating in the Monitoring the Future study. Age 29/30 data were collected from 2005 to 2013; age 35 data were collected from 2010 to 2018. Multivariable models regressed age 35 past-5-year AUD symptoms (vs. nondisordered drinking/abstinence) on age 29/30 past-2-week drinking intensity (no/low [0-4] drinking, binge [5-9] drinking, high-intensity [10+] drinking), with key covariates being controlled for. At age 35, 32.6% (SE = 1.50) of respondents reported AUD symptoms. AUD symptoms at age 35 were reported by 77.5% (SE = 4.79) of participants who reported age 29/30 high-intensity drinking and 60.6% (SE = 3.95) of participants who reported age 29/30 binge drinking. Age 35 past-5-year abstinence was reported by almost no respondents reporting age 29/30 binge drinking or high-intensity drinking. AUD symptoms at age 35 were significantly more likely for those who reported binge (adjusted multivariable odds ratio [AOR] = 5.61, 95% CI [3.79, 8.30], p < .001) or high-intensity (AOR = 12.26, 95% CI [6.70, 22.41], p < .001) drinking versus no/low drinking at age 29/30. The likelihood of having AUD symptoms was significantly higher for high-intensity than for binge drinkers (AOR = 2.18, 95% CI [1.14, 4.19], p = .019). Nearly 80% of those young adults who reported engaging in high-intensity drinking (10+ drinks in a row) at age 29/30 later reported AUD symptoms at age 35. High-intensity drinking appears to be a strong prospective marker of risk for AUD symptoms among adults in the United States.

Identifiants

pubmed: 34100704
pmc: PMC8328234

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

362-367

Subventions

Organisme : NIAAA NIH HHS
ID : R01 AA023504
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA001411
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA016575
Pays : United States

Références

Soc Psychiatry Psychiatr Epidemiol. 2020 Jan;55(1):101-110
pubmed: 30903234
J Stud Alcohol Drugs. 2016 Nov;77(6):881-888
pubmed: 27797689
Alcohol Clin Exp Res. 2006 Feb;30(2):243-52
pubmed: 16441273
Psychol Med. 2015 Oct;45(14):3047-58
pubmed: 26118496
J Stud Alcohol Drugs. 2018 Jul;79(4):567-577
pubmed: 30079872
Lancet. 2005 Feb 5-11;365(9458):519-30
pubmed: 15705462
Alcohol Clin Exp Res. 2016 Feb;40(2):256-9
pubmed: 26842244
Biol Psychiatry. 2014 May 15;75(10):798-806
pubmed: 24094754
Am J Prev Med. 2011 Nov;41(5):516-24
pubmed: 22011424
Alcohol Clin Exp Res. 2010 Nov;34(11):1871-8
pubmed: 20662803
JAMA Psychiatry. 2015 Aug;72(8):757-66
pubmed: 26039070
Drug Alcohol Depend. 2007 Apr;88 Suppl 1:S38-49
pubmed: 17257781
Subst Abuse. 2016 May 25;9(Suppl 1):41-57
pubmed: 27257384
Subst Abus. 2016 Oct-Dec;37(4):597-605
pubmed: 27092592
Drug Alcohol Depend. 1996 Jun;41(2):101-12
pubmed: 8809498
Psychol Addict Behav. 2017 Nov;31(7):775-785
pubmed: 28933869
Am J Prev Med. 2010 Feb;38(2):201-7
pubmed: 20117577
Drug Alcohol Depend. 2003 Jul 20;71(1):7-16
pubmed: 12821201
Psychol Med. 2006 Jan;36(1):109-18
pubmed: 16194286
J Adolesc Health. 2004 Sep;35(3):245-54
pubmed: 15313508
Am J Drug Alcohol Abuse. 2004 Aug;30(3):659-84
pubmed: 15540499
PLoS Med. 2011 Feb 08;8(2):e1000413
pubmed: 21346802
Addict Behav. 2017 Nov;74:134-139
pubmed: 28628871
J Stud Alcohol Drugs. 2011 Jan;72(1):106-16
pubmed: 21138717
Alcohol Clin Exp Res. 2017 Oct;41(10):1754-1759
pubmed: 28800154
Am J Prev Med. 2017 Jun;52(6):717-727
pubmed: 28526355
J Stud Alcohol Drugs. 2015 May;76(3):378-88
pubmed: 25978823
Soc Sci Med. 2020 Jan;244:112664
pubmed: 31726267
Prev Chronic Dis. 2014 Jun 26;11:E109
pubmed: 24967831
Drug Alcohol Depend. 2019 Nov 1;204:107580
pubmed: 31585359
Prev Sci. 2019 Apr;20(3):394-406
pubmed: 29542004
Drug Alcohol Depend. 2019 Jan 1;194:238-243
pubmed: 30466041
J Stud Alcohol Drugs. 2012 Sep;73(5):772-82
pubmed: 22846241
Drug Alcohol Depend. 2019 Jan 1;194:45-50
pubmed: 30399499
J Consult Clin Psychol. 1998 Jun;66(3):474-83
pubmed: 9642885
Sci Rep. 2018 Aug 22;8(1):12624
pubmed: 30135518
Am J Psychiatry. 2017 Nov 1;174(11):1094-1101
pubmed: 28774194
J Stud Alcohol. 2001 Mar;62(2):150-7
pubmed: 11327181

Auteurs

Megan E Patrick (ME)

Institute for Social Research, University of Michigan, Ann Arbor, Michigan.

Rebecca J Evans-Polce (RJ)

Center for the Study of Drugs, Alcohol, Smoking and Health, School of Nursing, University of Michigan, Ann Arbor, Michigan.

Michael J Parks (MJ)

Institute for Translational Research in Children's Mental Health, Minneapolis, Minnesota.

Yvonne M Terry-McElrath (YM)

Institute for Social Research, University of Michigan, Ann Arbor, Michigan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH